Condition: Bacteriuria · Spinal Cord Injuries · Asymptomatic Bacteriuria · Sponsor: Barbara Trautner
This is a Phase 1b study to assess the safety, tolerability, PK, and PD of investigational phage therapy (IP) in adults with SCI and bladder colonization (ASB). It is a single-center, randomized, double-blind, placebo-controlled study in adults with SCI with neurogenic bladders and bacteriuria who use indwelling catheters, or who require intermittent catheterization for bladder drainage.
This description comes directly from the study's public registry record.
Barbara W Trautner, MD, PhD · 314 747 5258 · trautner@wustl.edu
Rogelio Hernandez, MS · hrogelio@wustl.edu
Always discuss trial participation with your own doctor first.
| Washington University in St Louis | St Louis, Missouri, United States | Recruiting |
| Michael E. DeBakey VA Medical Center | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06559618